Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 12, 2009
Grant Date -
May 5, 2005
app pub date -
Dec 1, 2004
filing date -
Apr 20, 2001
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
can be one of a variety of substituents, including hydrogen or alkyl, and D is a moiety that enhances the pharmacological effects, promotes absorption or blood-brain barrier penetration of the derivative or analogue. The moiety A has a six-membered ring fused to a five-membered ring. The moiety A can have one, two, or three nitrogen atoms in the five membered ring. The moiety A can be a tetrahydroindolone moiety. The moiety B can be one of a variety of moieties, including moieties having nootropic activity or other biological or physiological activity.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully